LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products that improve vision. Our lead program is an aceclidine based eye drop designed to restore the loss of near vision associated with presbyopia. Presbyopia impacts almost two billion people globally and more than 120 million people in the US. LENZ Therapeutics is headquartered in San Diego, California, and is backed by multiple blue-chip venture capital investors.
Location: United States, California, Solana Beach
Employees: 1-10
Total raised: $130.5M
Investors 2
| Date | Name | Website |
| - | RA Capital... | racap.com |
| - | Alpha Wave... | alphawaveg... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 07.03.2023 | Series B | $83.5M | - |
| 14.08.2021 | Series A | $47M | - |
Mentions in press and media 88
Show more